{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:12:40Z","timestamp":1771305160901,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11892-022-01495-8","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T08:08:46Z","timestamp":1668845326000},"page":"571-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["SHORT Syndrome: an Update on Pathogenesis and Clinical Spectrum"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9612-6983","authenticated-orcid":false,"given":"Naama Fisch","family":"Shvalb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"1","key":"1495_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93(1):141\u20139.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"1495_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","volume":"93","author":"KK Chudasama","year":"2013","unstructured":"Chudasama KK, Winnay J, Johansson S, Claudi T, K\u00f6nig R, Haldorsen I, et al. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet. 2013;93(1):150\u20137.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"1495_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","volume":"93","author":"DA Dyment","year":"2013","unstructured":"Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ, et al. Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet. 2013;93(1):158\u201366.","journal-title":"Am J Hum Genet."},{"issue":"2","key":"1495_CR4","first-page":"39","volume":"11","author":"RJ Gorlin","year":"1975","unstructured":"Gorlin RJ, Cervenka J, Moller K, Horrobin M, Witkop CJ. Malformation syndromes A selected miscellany. Birth Defects Orig Artic Ser. 1975;11(2):39\u201350.","journal-title":"Birth Defects Orig Artic Ser."},{"issue":"2","key":"1495_CR5","first-page":"423","volume":"11","author":"JA Sensenbrenner","year":"1975","unstructured":"Sensenbrenner JA, Hussels IE, Levin LS. A low birthweight syndrome,\u202f? Rieger syndrome. Birth Defects Orig Artic Ser. 1975;11(2):423\u20136.","journal-title":"Birth Defects Orig Artic Ser."},{"key":"1495_CR6","doi-asserted-by":"crossref","unstructured":"Avila M, Dyment DA, Sagen JV, St-Onge J, Moog U, Chung BHY, et al. Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: towards recommendation for molecular testing and management. Clin Genet. 2015.\u00a0An important overview of a large case series with SHORT syndrome.","DOI":"10.1111\/cge.12688"},{"key":"1495_CR7","unstructured":"Innes AM, Dyment DA. SHORT Syndrome. 2014 May 15 [Updated 2020 Jun 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.\u00a0Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK201365\/"},{"issue":"4","key":"1495_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133\u2013223.","journal-title":"Physiol Rev."},{"issue":"3","key":"1495_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","volume":"13","author":"B Vanhaesebroeck","year":"2012","unstructured":"Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012;13(3):195\u2013203.\u00a0An excellent and in-depth perspective on the PI3K signaling pathway and its significance in humans.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"8","key":"1495_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/sj.ijo.0802961","volume":"29","author":"D Aubin","year":"2005","unstructured":"Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obes. 2005;29(8):1006\u20139.","journal-title":"Int J Obes."},{"issue":"17","key":"1495_CR11","doi-asserted-by":"publisher","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","volume":"1","author":"I Huang-Doran","year":"2016","unstructured":"Huang-Doran I, Tomlinson P, Payne F, Gast A, Sleigh A, Bottomley W, et al. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight. 2016;1(17):e88766.","journal-title":"JCI Insight."},{"issue":"1","key":"1495_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s13340-020-00455-5","volume":"12","author":"R Kushi","year":"2021","unstructured":"Kushi R, Hirota Y, Ogawa W. Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway. Diabetol Int. 2021;12(1):62\u20137.\u00a0An interesting overview which provides insight on SHORT syndrome as being primarily an insulin resistance syndrome.","journal-title":"Diabetol Int."},{"issue":"2","key":"1495_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1507\/endocrj.EJ21-0725","volume":"69","author":"W Ogawa","year":"2022","unstructured":"Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, et al. New classification and diagnostic criteria for insulin resistance syndrome. Endocr J. 2022;69(2):107\u201313.","journal-title":"Endocr J."},{"key":"1495_CR14","doi-asserted-by":"publisher","first-page":"101020","DOI":"10.1016\/j.molmet.2020.101020","volume":"40","author":"A Kwok","year":"2020","unstructured":"Kwok A, Zvetkova I, Virtue S, Luijten I, Huang-Doran I, Tomlinson P, et al. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure. Mol Metab. 2020;40:101020.\u00a0An important study that provides insight to the specific pathogenesis of SHORT syndrome which differentiates it from other forms of\u00a0lipodystrophies.","journal-title":"Mol Metab."},{"issue":"3","key":"1495_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cmet.2012.02.001","volume":"15","author":"A Ortega-Molina","year":"2012","unstructured":"Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, Mu\u00f1oz-Martin M, G\u00f3mez-L\u00f3pez G, Ca\u00f1amero M, et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 2012;15(3):382\u201394.","journal-title":"Cell Metab."},{"key":"1495_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molmet.2019.10.010","volume":"31","author":"A Gomez-Hernandez","year":"2020","unstructured":"Gomez-Hernandez A, Lopez-Pastor AR, Rubio-Longas C, Majewski P, Beneit N, Viana-Huete V, et al. Specific knockout of p85\u03b1 in brown adipose tissue induces resistance to high-fat diet-induced obesity and its metabolic complications in male mice. Mol Metab. 2020;31:1\u201313.","journal-title":"Mol Metab."},{"issue":"7","key":"1495_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2337\/db17-1509","volume":"67","author":"MH Solheim","year":"2018","unstructured":"Solheim MH, Winnay JN, Batista TM, Molven A, Nj\u00f8lstad PR, Kahn CR. Mice carrying a dominant-negative human PI3K mutation are protected from obesity and hepatic steatosis but not diabetes. Diabetes. 2018;67(7):1297\u2013309.","journal-title":"Diabetes."},{"issue":"4","key":"1495_CR18","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1172\/JCI84005","volume":"126","author":"JN Winnay","year":"2016","unstructured":"Winnay JN, Solheim MH, Dirice E, Sakaguchi M, Noh H-L, Kang HJ, et al. PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Invest. 2016;126(4):1401\u201312.\u00a0An important study in a mouse model on the effects of PI3K mutations in different systems.","journal-title":"J Clin Invest."},{"issue":"3","key":"1495_CR19","first-page":"403","volume":"5","author":"DF Restuccia","year":"2012","unstructured":"Restuccia DF, Hynx D, Hemmings BA. Loss of PKB\u03b2\/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo. Dis Model Mech. 2012;5(3):403\u201311.","journal-title":"Dis Model Mech."},{"issue":"6","key":"1495_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/cdd.2009.194","volume":"17","author":"R Gherzi","year":"2010","unstructured":"Gherzi R, Trabucchi M, Ponassi M, Gallouzi IE, Rosenfeld MG, Briata P. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ. 2010;17(6):975\u201383.","journal-title":"Cell Death Differ."},{"issue":"5","key":"1495_CR21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1210\/me.2008-0001","volume":"22","author":"A Mukherjee","year":"2008","unstructured":"Mukherjee A, Rotwein P. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol. 2008;22(5):1238\u201350.","journal-title":"Mol Endocrinol."},{"issue":"11","key":"1495_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/humu.22853","volume":"36","author":"P Prontera","year":"2015","unstructured":"Prontera P, Micale L, Verrotti A, Napolioni V, Stangoni G, Merla G. A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum Mutat. 2015;36(11):1043\u20137.","journal-title":"Hum Mutat."},{"key":"1495_CR23","doi-asserted-by":"crossref","unstructured":"Alcantara D, Elmslie F, Tetreault M, Bareke E, Hartley T, Care4Rare Consortium, et al. SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase C\u025b) impairing TORC2-dependent AKT activation. Hum Mol Genet. 2017 Oct 1;26(19):3713\u20133721.","DOI":"10.1093\/hmg\/ddx256"},{"issue":"1","key":"1495_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cge.13746","volume":"98","author":"E Ranza","year":"2020","unstructured":"Ranza E, Guimier A, Verloes A, Capri Y, Marques C, Auclair M, et al. Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants. Clin Genet. 2020;98(1):10\u20138.\u00a0On the newly recognized overlap between Noonan syndrome and SHORT syndrome.","journal-title":"Clin Genet."},{"key":"1495_CR25","first-page":"105566562110268","volume":"2","author":"S Mubeen","year":"2021","unstructured":"Mubeen S, Gibson C, Mubeen R, Mansour S, Evans RD. SHORT syndrome: systematic appraisal of the medical and dental phenotype. Cleft Palate Craniofac J. 2021;2:10556656211026860.\u00a0A recent update on the clinical phenotype of this rare disorder.","journal-title":"Cleft Palate Craniofac J."},{"key":"1495_CR26","first-page":"9","volume":"23","author":"S-H Kim","year":"2021","unstructured":"Kim S-H, Kim M, Yim J, Kim M, Jang D-H. Transient neonatal diabetes mellitus in SHORT syndrome: a case report. Front Pediatr. 2021;23:9.","journal-title":"Front Pediatr."},{"issue":"12","key":"1495_CR27","doi-asserted-by":"publisher","first-page":"E335","DOI":"10.1002\/ajh.25998","volume":"95","author":"A Marzollo","year":"2020","unstructured":"Marzollo A, Maestrini G, La Starza R, Elia L, Malfona F, Pierini T, Tretti Parenzan C, Coppe A, Bortoluzzi S, Biffi A, Mecucci C, Bresolin S, Testi AM. A novel germline variant in PIK3R1 results in SHORT syndrome associated with TAL\/LMO T-cell acute lymphoblastic leukemia. Am J Hematol. 2020;95(12):E335\u20138.","journal-title":"Am J Hematol."},{"issue":"5","key":"1495_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s10875-016-0281-6","volume":"36","author":"S Petrovski","year":"2016","unstructured":"Petrovski S, Parrott RE, Roberts JL, Huang H, Yang J, Gorentla B, et al. Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature. J Clin Immunol. 2016;36(5):462\u201371.","journal-title":"J Clin Immunol."},{"key":"1495_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","volume":"179","author":"M Bravo Garc\u00eda-Morato","year":"2017","unstructured":"Bravo Garc\u00eda-Morato M, Garc\u00eda-Mi\u00f1a\u00far S, Molina Garicano J, Santos Simarro F, Del Pino Molina L, L\u00f3pez-Granados E, et al. Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two. Clin Immunol. 2017;179:77\u201380.","journal-title":"Clin Immunol."},{"issue":"10","key":"1495_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/ajmg.a.32250","volume":"146A","author":"W Reardon","year":"2008","unstructured":"Reardon W, Temple IK. Nephrocalcinosis and disordered calcium metabolism in two children with SHORT syndrome. Am J Med Genet A. 2008;146A(10):1296\u20138.","journal-title":"Am J Med Genet A."},{"issue":"2","key":"1495_CR31","first-page":"315","volume":"119","author":"RK Semple","year":"2009","unstructured":"Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest. 2009;119(2):315\u201322.","journal-title":"J Clin Invest."},{"issue":"3","key":"1495_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2265.2010.03810.x","volume":"73","author":"RK Semple","year":"2010","unstructured":"Semple RK, Williams RM, Dunger DB. What is the best management strategy for patients with severe insulin resistance? Clin Endocrinol (Oxf). 2010;73(3):286\u201390.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"1495_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00125-015-3524-9","volume":"58","author":"D Jakubowicz","year":"2015","unstructured":"Jakubowicz D, Wainstein J, Ahr\u00e9n B, Bar-Dayan Y, Landau Z, Rabinovitz HR, et al. High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial. Diabetologia. 2015;58(5):912\u20139.","journal-title":"Diabetologia."},{"issue":"5","key":"1495_CR34","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jdi.12825","volume":"9","author":"T Hamaguchi","year":"2018","unstructured":"Hamaguchi T, Hirota Y, Takeuchi T, Nakagawa Y, Matsuoka A, Matsumoto M, et al. Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter 2 inhibitor. J Diabetes Investig. 2018;9(5):1224\u20137.","journal-title":"J Diabetes Investig."},{"issue":"1","key":"1495_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1507\/endocrj.EJ20-0291","volume":"68","author":"Y Masunaga","year":"2021","unstructured":"Masunaga Y, Fujisawa Y, Muramatsu M, Ono H, Inoue T, Fukami M, et al. Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review. Endocr J. 2021;68(1):111\u20137.","journal-title":"Endocr J."},{"issue":"10","key":"1495_CR36","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jdi.13549","volume":"12","author":"X Yin","year":"2021","unstructured":"Yin X, Liu J, Feng R, Xu M, Liu J. Novel PIK3R1 mutation of SHORT syndrome: a case report with a 6-month follow up. J Diabetes Investig. 2021;12(10):1919\u201322.","journal-title":"J Diabetes Investig."},{"issue":"11","key":"1495_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13098-019-0477-z","volume":"1","author":"KC Lewandowski","year":"2019","unstructured":"Lewandowski KC, D\u0105browska K, Brzozowska M, Kawalec J, Lewi\u0144ski A. Metformin paradoxically worsens insulin resistance in SHORT syndrome. Diabetol Metab Syndr. 2019;1(11):81.","journal-title":"Diabetol Metab Syndr."},{"issue":"9","key":"1495_CR38","doi-asserted-by":"publisher","first-page":"e1385","DOI":"10.1002\/mgg3.1385","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ji B, Li J, Li Y, Zhang M, Ban B. SHORT syndrome in two Chinese girls: a case report and review of the literature. Mol Genet Genomic Med. 2020;8(9):e1385.","journal-title":"Mol Genet Genomic Med."},{"key":"1495_CR39","doi-asserted-by":"crossref","unstructured":"Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history. Int J Mol Sci. 2021;22(5).","DOI":"10.3390\/ijms22052596"},{"issue":"12","key":"1495_CR40","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101(12):4500\u201311.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"1495_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/19336950.2016.1164373","volume":"10","author":"D Gavello","year":"2016","unstructured":"Gavello D, Carbone E, Carabelli V. Leptin-mediated ion channel regulation: PI3K pathways, physiological role, and therapeutic potential. Channels. 2016;10(4):282\u201396.","journal-title":"Channels."},{"issue":"13","key":"1495_CR42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2147\/DMSO.S206053","volume":"6","author":"C Bagias","year":"2020","unstructured":"Bagias C, Xiarchou A, Bargiota A, Tigas S. Familial partial lipodystrophy (FPLD): recent insights. Diabetes Metab Syndr Obes. 2020;6(13):1531\u201344.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"7","key":"1495_CR43","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1651-2227.1994.tb13142.x","volume":"83","author":"CF Verge","year":"1994","unstructured":"Verge CF, Donaghue KC, Williams PF, Cowell CT, Silink M. Insulin-resistant diabetes during growth hormone therapy in a child with SHORT syndrome. Acta Paediatr. 1994;83(7):786\u20138.","journal-title":"Acta Paediatr."},{"issue":"5","key":"1495_CR44","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/ajmg.a.62660","volume":"188","author":"ACG Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves ACG, Moretti PN, Cordoba MS, Oliveira RS, Lopes FSC, Oliveira SF, et al. SHORT syndrome in an adult Brazilian patient. Am J Med Genet A. 2022;188(5):1635\u20138.","journal-title":"Am J Med Genet A."}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-022-01495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-022-01495-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-022-01495-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T08:14:02Z","timestamp":1669796042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-022-01495-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1007\/s11892-022-01495-8","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"10 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}